Best Sermorelin Providers in 2026 — Ranked & Reviewed
Sermorelin is a growth-hormone-releasing hormone analog prescribed for body composition, recovery, and sleep. It is prescription-only in the US, so where you buy it matters — the market is full of grey-market "research peptide" sellers operating outside a doctor-patient relationship. Every provider below is a telehealth clinic we independently score, and each one prescribes through a licensed clinician. This page is ordered by that score; where a clinic publishes a sermorelin price we show it in the table, and most do not — they quote it after your consultation. If cost is what you are optimising for, the price-ranked version of this list is at /best/cheapest-sermorelin.
Lowest verified price: $89/mo108 providers compared
New to Sermorelin? Read our full Sermorelin guide — evidence, dosing, safety and side effects.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
108 sermorelin providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.
- ★ Editor's Pick
compounded or brand-name GLP-1 with named pharmacy partners, 50 states
From /moCheck pricingCoverage50 statesMedicationsNAD+Sermorelin - Nationwide Coverage
best overall value
From /mo$99Coverage50 statesMedicationsNAD+Sermorelin - Best Budget
mainstream telehealth GLP-1 access
From /mo$89Coverage50 statesMedicationsGlutathioneNAD+Sermorelin - Transparent Pricing
Low-cost compounded GLP-1 nationwide, no membership required
From /moCheck pricingCoverage50 statesMedicationsGlutathioneNAD+Sermorelin bilingual, LegitScript-certified compounded GLP-1
From /moCheck pricingCoverage50 statesMedicationsGlutathioneNAD+Sermorelinphysician-led, pharmacy-transparent compounded GLP-1 with brand-name options
From /mo$179Coverage50 statesMedicationsGlutathioneNAD+Sermorelincompounded semaglutide and tirzepatide at a flat monthly price
From /moCheck pricingCoverageCheck intakeMedicationsGlutathioneNAD+Sermorelincompounded GLP-1 with five named LegitScript-certified pharmacy partners
From /moCheck pricingCoverage50 statesMedicationsNAD+Sermorelin
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick compounded or brand-name GLP-1 with named pharmacy partners, 50 states | Check pricing | NAD+Sermorelin | 50 states | Visit → | |
Nationwide Coverage best overall value | $99 | NAD+Sermorelin | 50 states | Visit → | |
Best Budget mainstream telehealth GLP-1 access | $89 | GlutathioneNAD+Sermorelin | 50 states | Visit → | |
Transparent Pricing Low-cost compounded GLP-1 nationwide, no membership required | Check pricing | GlutathioneNAD+Sermorelin | 50 states | Visit → | |
 bilingual, LegitScript-certified compounded GLP-1 | Check pricing | GlutathioneNAD+Sermorelin | 50 states | Visit → | |
 physician-led, pharmacy-transparent compounded GLP-1 with brand-name options | $179 | GlutathioneNAD+Sermorelin | 50 states | Visit → | |
 compounded semaglutide and tirzepatide at a flat monthly price | Check pricing | GlutathioneNAD+Sermorelin | Check intake | Visit → | |
 compounded GLP-1 with five named LegitScript-certified pharmacy partners | Check pricing | NAD+Sermorelin | 50 states | Visit → |
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
Detailed Reviews
A note on prices below: any dollar figure in these provider summaries refers to that clinic’s GLP‑1 weight-loss program, not to Sermorelin. The Sermorelin price is the one beside each clinic in the comparison table above, read from that clinic’s own product page. Where it reads “Check pricing”, the clinic prescribes Sermorelin but publishes no price for it — you are quoted after the consultation.
Vytora Health
Best for: compounded or brand-name GLP-1 with named pharmacy partners, 50 states
Vytora Health is a 50-state-plus-DC telehealth platform offering compounded semaglutide and tirzepatide alongside brand-name Mounjaro and Zepbound, plus NAD+ and sermorelin peptides. It names its pharmacy partners publicly — Vials Pharmacy and Greenwich Biosciences — and discloses its operating physician group, uncommon transparency for the category. Compounded semaglutide runs $180/mo ($150 on a 3-month bundle) and tirzepatide $249/mo ($200 bundled).
Score Breakdown
Pros
- ✓All 50 states plus DC, with per-state video-vs-audio compliance disclosed
- ✓Both compounded and brand-name options on one platform — uncommon
- ✓LegitScript Approved and HIPAA compliant
- ✓Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
- ✓Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)
- ✓Competitive monthly pricing ($180 sema / $249 tirz) plus a 3-month bundle saving 17%
- ✓Brand-name Mounjaro and Zepbound available at $1,399/mo for FDA-approved options
Cons
- ✗Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
- ✗Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
- ✗Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
- ✗Initial consultation cost not shown on the public pricing page
- ✗Limited per-prescriber state licensure detail
CoreAge Rx
Verified partnerBest for: best overall value
CoreAge Rx offers LegitScript-verified compounded semaglutide and tirzepatide with free 2-day shipping to all 50 states. Backed by licensed physicians and 24/7 support, it delivers the most competitive pricing in the compounded GLP-1 space.
Score Breakdown
Pros
- ✓LegitScript certified — rigorous pharmacy standards
- ✓Free 2-day shipping nationwide
- ✓Both semaglutide and tirzepatide available
- ✓Lowest per-month pricing in the compounded segment
- ✓24/7 support team
- ✓All 50 states covered
Cons
- ✗Compounded only — no brand-name Ozempic or Wegovy
- ✗Newer brand with fewer independent reviews than legacy players
bmiMD
Verified partnerBest for: mainstream telehealth GLP-1 access
Medical weight loss clinic offering GLP-1 prescriptions through telehealth.
Score Breakdown
Pros
- ✓Both semaglutide and tirzepatide available
Cons
- ✗Cheapest advertised rates require a 12-month prepaid plan — month-to-month is $129 for semaglutide and $139 for sermorelin injection
Kongo
Best for: Low-cost compounded GLP-1 nationwide, no membership required
Kongo (Kongo Health Inc.) is a transparent, no-membership telehealth platform offering compounded GLP-1 weight-loss medication in all 50 states: compounded semaglutide at $119/month and tirzepatide at $229/month, with the provider visit, supplies, and free shipping always included. A 4-minute intake (no video call) gets a licensed-provider decision within 24 hours; prescriptions are compounded by a licensed US pharmacy. Kongo also offers longevity treatments (NAD+, sermorelin). It carries verifiable LegitScript certification; compounded meds are not FDA-approved.
Score Breakdown
Pros
- ✓Among the lowest compounded GLP-1 prices: semaglutide $119/month and tirzepatide $229/month
- ✓Available in all 50 states with no membership fee, and provider, supplies, and free shipping always included
- ✓Verifiable LegitScript certification (seal ID 45229340)
- ✓Fast and simple: 4-minute intake with no video call and provider approval within 24 hours
- ✓Also offers longevity treatments (NAD+, sermorelin, glutathione) if you want more than GLP-1
Cons
- ✗Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- ✗The compounding pharmacy is described only as a 'licensed US pharmacy' and not named
- ✗Newer brand; member testimonials are the main social proof
- ✗Some verticals (Longevity, Intimacy) are still listed as 'coming soon'
REMEVi
Best for: bilingual, LegitScript-certified compounded GLP-1
REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated. It offers compounded semaglutide (from $199/mo on the 52-week plan) and tirzepatide (from $269/mo), provider-managed with weekly titration and overnight shipping from an NPI-verified pharmacy, at the same price every month with no hidden fees and cancel-anytime. REMEVi is LegitScript-certified and licensed in all 50 states plus DC. Compounded meds are not FDA-approved (disclosed); the pharmacy is NPI-verified but not named.
Score Breakdown
Pros
- ✓The first bilingual GLP-1 clinic — care delivered in English and Spanish by clinicians trained in both, not auto-translated
- ✓Compounded semaglutide from $199/mo and tirzepatide from $269/mo on the 52-week plan, with the same price every month (no titration price hikes)
- ✓LegitScript-certified and licensed in all 50 states + DC, with an NPI-verified pharmacy and overnight shipping
- ✓Transparent all-inclusive pricing with no hidden fees and cancel anytime; full legal suite (Privacy, Terms, HIPAA, Refund)
Cons
- ✗Lowest pricing requires a 52-week commitment — month-to-month is higher ($279 semaglutide / $339 tirzepatide)
- ✗Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy or Zepbound
- ✗The specific compounding pharmacy is not named (described as 'NPI-verified')
- ✗A newer, patient-founded clinic; press mentions (Fortune, AP, Reuters) are syndicated PR, not editorial endorsements
How to choose a sermorelin provider
Sermorelin is a growth-hormone-releasing hormone analog. The brand that once held an FDA approval (Geref, for pediatric GH deficiency) is discontinued, so everything sold today is compounded and prescription-only — which makes the prescriber and the pharmacy the whole decision.
What to look for
- A licensed prescriber and a named pharmacy. The meaningful line in this market is not between clinics — it is between clinics and grey-market sellers. Confirm a licensed clinician reviews your intake and that the clinic names the 503A or 503B pharmacy that compounds your vial.
- Baseline and follow-up IGF-1. Sermorelin works by raising your own growth hormone, and IGF-1 is how that response is measured. A clinic that draws it at baseline and rechecks it is managing the therapy; one that never measures it is only refilling it.
- Route, and what it costs you. Injection, sublingual tablet or troche, and nasal spray are all sold. Oral and sublingual forms are usually the cheapest per month, so decide which route you will actually stick to before comparing prices.
Red flags to avoid
- “Research peptides” sold without a prescriber. Vials labelled “for research use only — not for human consumption” are sold outside the drug-approval system entirely, with no verified identity, purity, or sterility. Every peptide in this category is prescription-only in the US; if no licensed clinician is writing a prescription, you are not buying the same product.
- No named 503A or 503B compounding pharmacy. There is no FDA-approved finished product for these peptides, so every legitimate dose comes from a compounding pharmacy. A clinic that will not name the pharmacy it dispenses through is asking you to trust an unverifiable supply chain.
- “FDA-approved” claimed for a compounded peptide. Compounded drugs are not FDA-approved, and saying otherwise is a marketing violation, not a technicality. Some peptides once held an approval for a different indication in a discontinued brand — that is not the same as the compounded product being approved.
- Outcome claims with no trial behind them. Most peptides in this category have mechanistic or early-phase evidence, not randomized outcome trials. A clinic promising a specific fat-loss, muscle, or anti-aging result is selling ahead of the evidence — check our evidence review for the molecule before you commit.
- No baseline labs or follow-up for hormone-axis peptides. Growth-hormone secretagogues raise IGF-1, which is the point and also the thing to monitor. A clinic that never measures it cannot tell whether you are responding or over-dosed.
Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.
How we rank & what counts as “legit”
Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.
Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].
Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- 503A pharmacy · Pharmacy and drug forms
- 503A vs 503B (pharmacy compounding) · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.